GB Patent

GB202016800D0 — Novel compounds

Assigned to Mission Therapeutics Ltd · Expires 2020-12-09 · 5y expired

What this patent protects

Patent listed against nintedanib-esylate.

Drugs covered by this patent

nintedanib-esylate (NINTEDANIB ESYLATE)

Patent Metadata

Patent number: GB202016800D0
Jurisdiction: GB
Classification: —
Expires: 2020-12-09
Drug substance claim: No
Drug product claim: No
Assignee: Mission Therapeutics Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.